Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers.
10.3346/jkms.2017.32.3.415
- Author:
Ha Youn LEE
1
;
Se Hoon LEE
;
Jae Kyung WON
;
Dong Soo LEE
;
Nak Jung KWON
;
Sun Mi CHOI
;
Jinwoo LEE
;
Chang Hoon LEE
;
Sang Min LEE
;
Jae Joon YIM
;
Chul Gyu YOO
;
Young Whan KIM
;
Sung Koo HAN
;
Young Sik PARK
Author Information
1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. mdyspark@gmail.com
- Publication Type:Original Article
- Keywords:
Lung Cancer;
Squamous Cell Carcinoma;
Never-Smoker;
Mutation;
TP53;
RAS;
STK11
- MeSH:
Carcinoma, Squamous Cell*;
Epithelial Cells*;
Female;
Genome;
Humans;
Incidence;
Lung Neoplasms;
Lung*;
Medical Records;
Retrospective Studies;
Risk Factors;
Seoul;
Smoke;
Smoking
- From:Journal of Korean Medical Science
2017;32(3):415-420
- CountryRepublic of Korea
- Language:English
-
Abstract:
Smoking is the major risk factor for lung squamous cell carcinoma (SCC), although a small number of lung SCCs occurs in never-smokers. The purpose of this study was to compare 50 hotspot mutations of lung SCCs between never-smokers and smokers. We retrospectively reviewed the medical records of patients newly diagnosed with lung SCC between January 1, 2011 and December 31, 2013 in the Seoul National University Hospital. Formalin-fixed, paraffin-embedded tumor samples were used for analysis of hotspot mutations. Fifty cancer-related genes in never-smokers were compared to those in ever-smokers. Of 379 lung SCC patients, 19 (5.0%) were never-smokers. The median age of these 19 patients was 67 years (interquartile range 57–73 years), and 10 of these patients were women (52.5%). The incidence rates of stage I, II, III, and IV disease in this group were 26.4%, 5.3%, 31.6%, and 36.8%, respectively, and sequencing was performed successfully in 14 cases. In the 26 lung SCC tumor samples (12 from never-smokers and 14 from ever-smokers) sequenced using personal genome machine, the most common mutations were in TP53 (75.0%), RAS (66.7%), and STK11 (33.3%), but mutations were also found in EGFR, KIT, and PTEN. The distribution of hotspot mutations in never-smokers was similar to that in ever-smokers. There was no significant difference in overall survival between the 2 groups. The 50 hotspot mutations of lung SCC in never-smokers were similar to those of ever-smokers.
